Navigation Links
Anemia Treatment for Cancer Patients Might Not be a Good Idea.

Many patients being treated for cancer complain of feeling weak and tried, and doctors often prescribe //an anemia treatment to relieve these symptoms however a new study suggests otherwise.

Since anemia has been associated with worse prognosis after radiotherapy, the doctors assumed the treatment would make patients feel better and improve results of the therapy, as well.

Not so, report German researchers , their study finds treating anemia in cancer patients with the drug erythropoietin (epoetin beta) may actually interfere with cancer treatment. Patients who did not receive the treatment had about a 60-percent better chance of surviving their cancer without a relapse than those who did receive the treatment.

The study involved 351 patients who received either erythropoietin or a placebo about two weeks before undergoing radiotherapy for head and neck cancers. While the drug was effective in treating the symptoms of anemia among the patients, the poorer outcomes seen in the drug group led researchers to conclude the benefits may not be worth the risks.

Researchers say although epoetin beta efficiently corrects anemia among patients undergoing curative radiotherapy, it is not associated with improved cancer control or survival. On the contrary, erythropoietin might impair disease control when manifest cancer is irradiated. However further research is in progress on this subject.
'"/>




Page: 1

Related medicine news :

1. Anemia may Lead to Physical Decline
2. Anemia Treatment for Cancer Patients
3. Anemia Treatment for Cancer Patients
4. Acute Toxicity Of Nano-Scale Zinc Powder: Severe Renal Damage And Anemia
5. Treatment of Sickle Cell Anemia Using Gene Therapy.
6. Treating Sickle Cell Anemia using Healthy Stem Cells
7. Anemia from Malaria Linked to a Protein MIF
8. EPO Effective For Cancer Patients Suffering From Anemia
9. Amgen introduces Autoinjector For Treating Anemia
10. Anemia Affects Both Body and Mind
11. Exercise alleviates Anemia in Breast cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2017)... ... June 28, 2017 , ... ... services, is proud to announce the guest speaker lineup* for its second annual ... Alliance of Healthcare Purchaser Coalitions; Dr. Keith Fernandez of Privia Health; and Lisa ...
(Date:6/28/2017)... Park, IL (PRWEB) , ... June 28, 2017 , ... David B. Sosin, ... Orland Park, Illinois, took over the post of 2nd Vice President for the Illinois ... Sosin was installed as the ISBA’s 3rd Vice President in 2016 following a state-wide election ...
(Date:6/28/2017)... ... , ... Park Systems , a leader in Atomic Force Microscopy (AFM) ... and Park customers on July 11, 2017 from 12-2pm at the Thirsty Bear Brewing ... of Park Systems, and Prof. Krishna Saraswat , Rickey/Nielsen Professor in the School ...
(Date:6/28/2017)... , ... June 28, 2017 , ... ... County and the surrounding regions access to insurance assistance and financial planning services, ... 25: Ministries to assist families in the region facing financial crisis. , Matthew ...
(Date:6/27/2017)... Fla. (PRWEB) , ... June 27, 2017 , ... ... today announced the appointment of Mike Finnegan to the position of Executive Vice ... years of experience in healthcare technology, telehealth and medical device sales leadership. He ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... AirXpanders, Inc. (ASX: AXP) (AirXpanders or Company), ... sale and distribution of the AeroForm® Tissue Expander System, ... commercial roll-out in the United States ... hundred (100) medical institutions and health systems, located throughout ... alternative for women who choose reconstructive surgery following a ...
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly ... announced that results from the Phase 3 MONARCH ... (CDK)4 & 6 inhibitor, in combination with fulvestrant, ... with fulvestrant alone in women with hormone-receptor-positive (HR+), ... breast cancer who have relapsed or progressed after ...
Breaking Medicine Technology: